Basic information Safety Supplier Related

2,6-DICHLORO-9-METHYL-9H-PURINE

Basic information Safety Supplier Related

2,6-DICHLORO-9-METHYL-9H-PURINE Basic information

Product Name:
2,6-DICHLORO-9-METHYL-9H-PURINE
Synonyms:
  • 2,6-DICHLORO-9-METHYL-9H-PURINE
  • 9-Methyl-2,6-dichloropurine
  • 2,6-dichloro-9-methyl-9H-purine176328
  • 2,6-Dichloro-9-Methylpurine
  • 9H-Purine, 2,6-dichloro-9-methyl-
  • 2,6-dichloro-9-methyl-1H-purine
  • Hexanoicacid,5-methyl-5-oxo-,ethylester
CAS:
2382-10-7
MF:
C6H4Cl2N4
MW:
203.03
Mol File:
Mol File
More
Less

2,6-DICHLORO-9-METHYL-9H-PURINE Chemical Properties

Melting point:
152-153℃
Boiling point:
307.2±52.0 °C(Predicted)
Density 
1.76
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
-0.90±0.10(Predicted)
Appearance
White to off-white Solid
InChI
InChI=1S/C6H4Cl2N4/c1-12-2-9-3-4(7)10-6(8)11-5(3)12/h2H,1H3
InChIKey
HWMJNDVUIMQFEW-UHFFFAOYSA-N
SMILES
N1C2C(=NC(Cl)=NC=2Cl)N(C)C=1
CAS DataBase Reference
2382-10-7
More
Less

Safety Information

Hazard Codes 
Xn
Risk Statements 
22
HS Code 
2933599590
More
Less

2,6-DICHLORO-9-METHYL-9H-PURINE Usage And Synthesis

Uses

2,6-DICHLORO-9-METHYLPURINE acts as a reagent in the synthesis of highly selective inhibitors of PI3K-δ used in the treatment of inflammatory diseases such as leukocyte related illnesses.

Synthesis

5451-40-1

74-88-4

2382-10-7

Procedure for the synthesis of 2,6-dichloro-9-methyl-9H-purine (15b): potassium carbonate (K2CO3, 0.270 g, 1.95 mmol) was added to an anhydrous DMF (1.0 mL) solution of 2,6-dichloro-9H-purine (0.120 g, 0.635 mmol) at 0°C followed by the addition of iodomethane (0.20 mL, 3.21 mmol). The reaction mixture was stirred continuously at 0 °C for 5 hours. Upon completion of the reaction, the reaction was quenched with water and extracted with ethyl acetate (EtOAc). The organic layers were combined, washed with saturated brine, dried over anhydrous magnesium sulfate (MgSO4), concentrated and purified by silica gel (SiO2) column chromatography with an elution gradient from 100% hexane to 100% ethyl acetate (EtOAc) to afford the target product 15b (83.0 mg, 0.409 mmol, 64% yield) as a colorless solid. The product characterization data were as follows: IR (ATR, neat) 3067, 1554, 1360, 1333, 1223, 1147 cm-1; 1H NMR (CDCl3, 600 MHz) δ 8.09 (s, 1H), 3.89 (s, 3H); 13C NMR (CDCl3, 150 MHz) δ 153.3, 152.7, 151.3, 146.4, 130.4, 30.4.

References

[1] Patent: WO2014/189830, 2014, A1. Location in patent: Page/Page column 35
[2] ACS Medicinal Chemistry Letters, 2012, vol. 3, # 12, p. 985 - 990
[3] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 12, p. 3486 - 3490
[4] Patent: US2011/237607, 2011, A1. Location in patent: Page/Page column 6; 7
[5] Patent: WO2016/91916, 2016, A1. Location in patent: Page/Page column 66

2,6-DICHLORO-9-METHYL-9H-PURINESupplier

Shanghai TBBMed Co.,Ltd Gold
Tel
021-50498136 13564881053
Email
products@tbbmed.com
Shanghai Vigor Biotechnology Co., Ltd. Gold
Tel
021-18017654 18017654809
Email
sales@vigorchem.cn
Shaoyuan Technology (Shanghai) Co., Ltd. Gold
Tel
021-50795510 4000665055
Email
sy-c5@accelachem.com
Beijing Ouhe Technology Co., Ltd
Tel
010-010-82967028 13522913783
Email
2355560935@qq.com
Shanghai civi chemical technology co.,Ltd
Tel
86-21-34053660
Email
sale@labgogo.com
More
Less

2,6-DICHLORO-9-METHYL-9H-PURINE(2382-10-7)Related Product Information